TELA Bio Sets the Stage for Growth: Public Offering of Common Stock and Pre-Funded Warrants Now Available
TELA Bio, Inc. Announces Pricing of Public Offering What You Need to Know On October 23, 2024, TELA Bio, Inc. (“TELA”), a leading medical technology company specializing in soft-tissue reconstruction, revealed the pricing of its underwritten public offering. The offering includes 12,000,000 shares of common stock at a price of $2.25 per share. Additionally, investors…